Literature DB >> 29233331

The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2018 Update on Outcomes and Quality.

Richard S D'Agostino1, Jeffrey P Jacobs2, Vinay Badhwar3, Felix G Fernandez4, Gaetano Paone5, David W Wormuth6, David M Shahian7.   

Abstract

Through nearly 3 decades of iterative refinement, The Society of Thoracic Surgeons Adult Cardiac Surgery Database has evolved into one of the most comprehensive and respected clinical data registries in health care. It is a widely acknowledged exemplar for accurately benchmarking risk-adjusted outcomes in cardiac surgery and underpins all quality measurement and improvement activities of The Society of Thoracic Surgeons. This is the latest in a series of annual reports that outlines current national aggregate outcomes and volume trends in cardiac surgery and summarizes database-related work in quality measurement and performance improvement during the past year.
Copyright © 2018 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Mesh：

Year:  2018        PMID： 29233331     DOI： 10.1016/j.athoracsur.2017.10.035

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  64 in total

1.  Successful extracorporeal membrane oxygenation assisted revascularisation in a high-risk elderly patient refused surgical treatment.

Authors:  Robertas Samalavičius; Lina Puodžiukaitė; Vytautas Abraitis; Ieva Norkienė; Nadežda Ščupakova; Justina Pekarskienė; Aleksejus Zorinas; Kęstutis Ručinskas; Pranas Šerpytis
Journal:  Acta Med Litu       Date:  2019

2.  Mortality Due to Aortic Stenosis in the United States, 2008-2017.

Authors:  Graham H Bevan; David A Zidar; Richard A Josephson; Sadeer G Al-Kindi
Journal:  JAMA       Date:  2019-06-11       Impact factor: 56.272

3.  The risk of mediastinitis and deep sternal wound infections with single and bilateral, pedicled and skeletonized internal thoracic arteries.

Authors:  Harold L Lazar
Journal:  Ann Cardiothorac Surg       Date:  2018-09

4.  Coronary artery bypass grafting-fifty years of quality initiatives since Favaloro.

Authors:  John J Squiers; Michael J Mack
Journal:  Ann Cardiothorac Surg       Date:  2018-07

Review 5.  In Search of the Ideal Valve: Optimizing Genetic Modifications to Prevent Bioprosthetic Degeneration.

Authors:  Benjamin Smood; Hidetaka Hara; David C Cleveland; David K C Cooper
Journal:  Ann Thorac Surg       Date:  2019-03-02       Impact factor: 4.330

6.  Survival As a Patient-Centered Outcome of Mental Health Care.

Authors:  Michael Schoenbaum
Journal:  Psychiatr Serv       Date:  2019-06-01       Impact factor: 3.084

Review 7.  Coronary Revascularization in High-Risk Stable Patients With Significant Comorbidities: Challenges in Decision-Making.

Authors:  Joshua Schulman-Marcus; Kellsey Peterson; Riju Banerjee; Sanjay Samy; Neil Yager
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-02-09

8.  Hyperoxia during cardiopulmonary bypass does not decrease cardiovascular complications following cardiac surgery: the CARDIOX randomized clinical trial.

Authors:  Osama Abou-Arab; Pierre Huette; Lucie Martineau; Clémence Beauvalot; Christophe Beyls; Estelle Josse; Gilles Touati; Olivier Bouchot; Belaïd Bouhemad; Momar Diouf; Emmanuel Lorne; Pierre-Grégoire Guinot
Journal:  Intensive Care Med       Date:  2019-10-01       Impact factor: 17.440

9.  Current quality reporting methods are not adequate for salvage cardiac operations.

Authors:  William Z Chancellor; J Hunter Mehaffey; Jared P Beller; Elizabeth D Krebs; Robert B Hawkins; Kenan Yount; Clifford E Fonner; Alan M Speir; Mohammed A Quader; Jeffrey B Rich; Leora T Yarboro; Nicholas R Teman; Gorav Ailawadi
Journal:  J Thorac Cardiovasc Surg       Date:  2019-01-26       Impact factor: 5.209

10.  The effects of remifentanil combined with propofol on the oxidative damage and the stress and inflammatory responses in cardiac surgery patients.

Authors:  Xiaojing Li; Hongxia Xiang; Wen Zhang; Chunling Peng
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.